-
Published17/09/2025
-
Today15/05/2026
-
Deadline31/08/2027
-
Opening of tenders31/08/2027
Utilities
- indicates text translated automatically in your browsing language
Medicines containing the active substance etanercept (ATC: L04AB01)
The open-house procedure for concluding non-exclusive discount agreements pursuant to Section 130a(8) SGB V for finished medicinal products containing the active substance etanercept (ATC: L04AB01) is terminated on 30.06.2026. It is no longer possible to join the procedure with publication number 268805-2026 as of 01.07.2026.
sen-info
Type: price
Description: Die Auftraggeberin oder ein von der Auftraggeberin beauftragtes Unternehmen (nachfolgend ebenfalls als Auftraggeberin bezeichnet) berechnet auf Basis der im Regelfall drei Monate nach Abschluss eines Abrechnungszeitraums vorliegenden Abrechnungsdaten gemäß § 300 SGB V die Höhe des der Auftraggeberin zustehenden Rabattbetrages.
Weight (percentage, exact): 1.0
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.